25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOA (BioAge Labs, Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze BioAge Labs, Inc together

I guess you are interested in BioAge Labs, Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – BioAge Labs, Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – BioAge Labs, Inc’s Price Targets

I'm going to help you getting a better view of BioAge Labs, Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioAge Labs, Inc

I send you an email if I find something interesting about BioAge Labs, Inc.

1. Quick Overview

1.1. Quick analysis of BioAge Labs, Inc (30 sec.)










1.2. What can you expect buying and holding a share of BioAge Labs, Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$9.46
Expected worth in 1 year
$23.99
How sure are you?
47.1%

+ What do you gain per year?

Total Gains per Share
$14.53
Return On Investment
387.5%

For what price can you sell your share?

Current Price per Share
$3.75
Expected price per share
$0 - $4.12
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BioAge Labs, Inc (5 min.)




Live pricePrice per Share (EOD)
$3.75
Intrinsic Value Per Share
$17.75 - $22.00
Total Value Per Share
$27.20 - $31.46

2.2. Growth of BioAge Labs, Inc (5 min.)




Is BioAge Labs, Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$323.1m-$173.3m$236.9m372.8%

How much money is BioAge Labs, Inc making?

Current yearPrevious yearGrowGrow %
Making money-$17.7m-$20.9m$3.1m17.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of BioAge Labs, Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BioAge Labs, Inc?

Welcome investor! BioAge Labs, Inc's management wants to use your money to grow the business. In return you get a share of BioAge Labs, Inc.

First you should know what it really means to hold a share of BioAge Labs, Inc. And how you can make/lose money.

Speculation

The Price per Share of BioAge Labs, Inc is $3.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioAge Labs, Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioAge Labs, Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.46. Based on the TTM, the Book Value Change Per Share is $3.63 per quarter. Based on the YOY, the Book Value Change Per Share is $-5.60 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioAge Labs, Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.62-16.5%-0.52-13.9%-0.61-16.4%-0.54-14.4%-0.34-9.0%
Usd Book Value Change Per Share0.277.3%3.6396.9%-5.60-149.2%1.7947.7%0.4612.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.277.3%3.6396.9%-5.60-149.2%1.7947.7%0.4612.2%
Usd Price Per Share5.79-6.65-0.00-5.32-1.56-
Price to Earnings Ratio-2.34--2.48-0.00--1.99--0.58-
Price-to-Total Gains Ratio21.09-11.24-11.24-11.24-
Price to Book Ratio0.61-0.72-0.00-0.58-0.17-
Price-to-Total Gains Ratio21.09-11.24-11.24-11.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.75
Number of shares266
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share3.631.79
Usd Total Gains Per Share3.631.79
Gains per Quarter (266 shares)966.39475.41
Gains per Year (266 shares)3,865.551,901.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1038663856019021892
2077317722038033794
301159711588057055696
401546215454076077598
501932819320095089500
60231932318601141011402
70270592705201331113304
80309243091801521315206
90347903478401711517108
100386563865001901619010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.05.00.00.0%0.05.00.00.0%5.012.00.029.4%12.013.00.048.0%
Book Value Change Per Share2.02.00.050.0%2.03.00.040.0%2.03.00.040.0%8.09.00.047.1%11.014.00.044.0%
Dividend per Share0.00.04.00.0%0.00.05.00.0%0.00.05.00.0%0.00.017.00.0%1.00.024.04.0%
Total Gains per Share2.02.00.050.0%2.03.00.040.0%2.03.00.040.0%8.09.00.047.1%11.014.00.044.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioAge Labs, Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2753.633-92%-5.596+2139%1.787-85%0.457-40%
Book Value Per Share--9.4571.860+408%-5.075+154%0.473+1899%1.285+636%
Current Ratio--12.85713.727-6%0.435+2855%11.068+16%3.993+222%
Debt To Asset Ratio--0.0981.100-91%7.689-99%2.418-96%1.147-91%
Debt To Equity Ratio--0.1090.046+136%-+100%0.037+195%1.248-91%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--517070088.000769294424.000-33%--769294424.000-33%769294424.000-33%
Eps---0.618-0.520-16%-0.613-1%-0.539-13%-0.337-46%
Ev To Ebitda Ratio---6.226-8.669+39%---8.669+39%-8.669+39%
Ev To Sales Ratio--infinfnan%--infnan%infnan%
Free Cash Flow Per Share---0.151-0.380+151%-0.249+65%-0.354+134%-0.272+80%
Free Cash Flow To Equity Per Share--0.5782.410-76%-0.278+148%1.872-69%0.588-2%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.651+54%
Intrinsic Value_10Y_max--22.005--------
Intrinsic Value_10Y_min--17.746--------
Intrinsic Value_1Y_max---0.891--------
Intrinsic Value_1Y_min---0.877--------
Intrinsic Value_3Y_max---0.318--------
Intrinsic Value_3Y_min---0.352--------
Intrinsic Value_5Y_max--3.100--------
Intrinsic Value_5Y_min--2.674--------
Market Cap128127000.000-54%197828088.000227126462.000-13%-+100%181701169.600+9%53441520.471+270%
Net Profit Margin----0%-0%-0%0.260-100%
Operating Margin----0%-0%-0%0.263-100%
Operating Ratio----0%-0%-0%8.834-100%
Pb Ratio0.397-54%0.6120.719-15%-+100%0.575+6%0.169+262%
Pe Ratio-1.516+35%-2.341-2.483+6%--100%-1.986-15%-0.584-75%
Price Per Share3.750-54%5.7906.648-13%-+100%5.318+9%1.564+270%
Price To Free Cash Flow Ratio-6.203+35%-9.577-5.310-45%--100%-4.248-56%-1.249-87%
Price To Total Gains Ratio13.661-54%21.09311.242+88%--11.242+88%11.242+88%
Quick Ratio--12.75813.508-6%0.372+3329%10.881+17%3.714+243%
Return On Assets---0.059-0.071+20%-0.808+1271%-0.218+270%-0.160+172%
Return On Equity---0.065-0.035-46%--100%-0.028-57%-0.311+375%
Total Gains Per Share--0.2753.633-92%-5.596+2139%1.787-85%0.457-40%
Usd Book Value--323127000.00063558000.000+408%-173396000.000+154%16167200.000+1899%45424702.588+611%
Usd Book Value Change Per Share--0.2753.633-92%-5.596+2139%1.787-85%0.457-40%
Usd Book Value Per Share--9.4571.860+408%-5.075+154%0.473+1899%1.285+636%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--517070088.000769294424.000-33%--769294424.000-33%769294424.000-33%
Usd Eps---0.618-0.520-16%-0.613-1%-0.539-13%-0.337-46%
Usd Free Cash Flow---5164000.000-12972000.000+151%-8503000.000+65%-12078200.000+134%-9411451.000+82%
Usd Free Cash Flow Per Share---0.151-0.380+151%-0.249+65%-0.354+134%-0.272+80%
Usd Free Cash Flow To Equity Per Share--0.5782.410-76%-0.278+148%1.872-69%0.588-2%
Usd Market Cap128127000.000-54%197828088.000227126462.000-13%-+100%181701169.600+9%53441520.471+270%
Usd Price Per Share3.750-54%5.7906.648-13%-+100%5.318+9%1.564+270%
Usd Profit---21129000.000-17777250.000-16%-20958000.000-1%-18413400.000-13%-12704397.412-40%
Usd Revenue----0%-0%-0%1493377.000-100%
Usd Total Gains Per Share--0.2753.633-92%-5.596+2139%1.787-85%0.457-40%
 EOD+2 -6MRQTTM+13 -19YOY+21 -75Y+17 -1510Y+21 -16

3.3 Fundamental Score

Let's check the fundamental score of BioAge Labs, Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.516
Price to Book Ratio (EOD)Between0-10.397
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.758
Current Ratio (MRQ)Greater than112.857
Debt to Asset Ratio (MRQ)Less than10.098
Debt to Equity Ratio (MRQ)Less than10.109
Return on Equity (MRQ)Greater than0.15-0.065
Return on Assets (MRQ)Greater than0.05-0.059
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of BioAge Labs, Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.034
Ma 20Greater thanMa 503.768
Ma 50Greater thanMa 1004.155
Ma 100Greater thanMa 2006.400
OpenGreater thanClose3.770
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About BioAge Labs, Inc

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Fundamental data was last updated by Penke on 2025-04-04 06:59:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ BioAge Labs, Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioAge Labs, Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y26.0%-26.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ BioAge Labs, Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -5.9% Return on Assets means thatΒ BioAge Labs, Inc generatedΒ $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioAge Labs, Inc:

  • The MRQ is -5.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-7.1%+1.2%
TTM-7.1%YOY-80.8%+73.8%
TTM-7.1%5Y-21.8%+14.8%
5Y-21.8%10Y-16.0%-5.8%
4.3.1.3. Return on Equity

Shows how efficient BioAge Labs, Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -6.5% Return on Equity means BioAge Labs, Inc generated $-0.07Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioAge Labs, Inc:

  • The MRQ is -6.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-3.5%-3.0%
TTM-3.5%YOY--3.5%
TTM-3.5%5Y-2.8%-0.7%
5Y-2.8%10Y-31.1%+28.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioAge Labs, Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient BioAge Labs, Inc is operatingΒ .

  • Measures how much profit BioAge Labs, Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioAge Labs, Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y26.3%-26.3%
4.3.2.2. Operating Ratio

Measures how efficient BioAge Labs, Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioAge Labs, Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y8.834-8.834
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioAge Labs, Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BioAge Labs, Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 12.86Β means the company has $12.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioAge Labs, Inc:

  • The MRQ is 12.857. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.727. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.857TTM13.727-0.870
TTM13.727YOY0.435+13.292
TTM13.7275Y11.068+2.658
5Y11.06810Y3.993+7.075
4.4.3.2. Quick Ratio

Measures if BioAge Labs, Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 12.76Β means the company can pay off $12.76 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioAge Labs, Inc:

  • The MRQ is 12.758. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.508. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.758TTM13.508-0.750
TTM13.508YOY0.372+13.136
TTM13.5085Y10.881+2.627
5Y10.88110Y3.714+7.167
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioAge Labs, Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioAge Labs, IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ BioAge Labs, Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.10Β means that BioAge Labs, Inc assets areΒ financed with 9.8% credit (debt) and the remaining percentage (100% - 9.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of BioAge Labs, Inc:

  • The MRQ is 0.098. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 1.100. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ0.098TTM1.100-1.002
TTM1.100YOY7.689-6.589
TTM1.1005Y2.418-1.318
5Y2.41810Y1.147+1.271
4.5.4.2. Debt to Equity Ratio

Measures ifΒ BioAge Labs, Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 10.9% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioAge Labs, Inc:

  • The MRQ is 0.109. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.046. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.109TTM0.046+0.063
TTM0.046YOY-+0.046
TTM0.0465Y0.037+0.009
5Y0.03710Y1.248-1.212
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings BioAge Labs, Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ BioAge Labs, Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.34 means the investor is paying $-2.34Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioAge Labs, Inc:

  • The EOD is -1.516. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.341. Based on the earnings, the company is expensive. -2
  • The TTM is -2.483. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.516MRQ-2.341+0.825
MRQ-2.341TTM-2.483+0.142
TTM-2.483YOY--2.483
TTM-2.4835Y-1.986-0.497
5Y-1.98610Y-0.584-1.402
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioAge Labs, Inc:

  • The EOD is -6.203. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.577. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.310. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.203MRQ-9.577+3.374
MRQ-9.577TTM-5.310-4.268
TTM-5.310YOY--5.310
TTM-5.3105Y-4.248-1.062
5Y-4.24810Y-1.249-2.998
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ BioAge Labs, Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.61 means the investor is paying $0.61Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioAge Labs, Inc:

  • The EOD is 0.397. Based on the equity, the company is cheap. +2
  • The MRQ is 0.612. Based on the equity, the company is cheap. +2
  • The TTM is 0.719. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.397MRQ0.612-0.216
MRQ0.612TTM0.719-0.107
TTM0.719YOY-+0.719
TTM0.7195Y0.575+0.144
5Y0.57510Y0.169+0.406
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets358,234
Total Liabilities35,107
Total Stockholder Equity323,127
 As reported
Total Liabilities 35,107
Total Stockholder Equity+ 323,127
Total Assets = 358,234

Assets

Total Assets358,234
Total Current Assets357,103
Long-term Assets1,131
Total Current Assets
Cash And Cash Equivalents 354,349
Other Current Assets 2,754
Total Current Assets  (as reported)357,103
Total Current Assets  (calculated)357,103
+/-0
Long-term Assets
Property Plant Equipment 791
Long Term Investments 100
Long-term Assets Other 240
Long-term Assets  (as reported)1,131
Long-term Assets  (calculated)1,131
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,775
Long-term Liabilities7,332
Total Stockholder Equity323,127
Total Current Liabilities
Short-term Debt 6,202
Short Long Term Debt 6,000
Accounts payable 1,996
Other Current Liabilities 11,751
Total Current Liabilities  (as reported)27,775
Total Current Liabilities  (calculated)25,949
+/- 1,826
Long-term Liabilities
Long term Debt 2,502
Capital Lease Obligations 202
Long-term Liabilities  (as reported)7,332
Long-term Liabilities  (calculated)2,704
+/- 4,628
Total Stockholder Equity
Retained Earnings -252,811
Accumulated Other Comprehensive Income 245
Other Stockholders Equity 575,693
Total Stockholder Equity (as reported)323,127
Total Stockholder Equity (calculated)323,127
+/-0
Other
Cash and Short Term Investments 354,349
Common Stock Shares Outstanding 10,727
Current Deferred Revenue7,826
Liabilities and Stockholders Equity 358,234
Net Debt -345,645
Net Invested Capital 331,629
Net Working Capital 329,328
Property Plant and Equipment Gross 1,162
Short Long Term Debt Total 8,704



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
43,600
124,146
118,810
114,079
117,236
118,868
162,443
152,440
144,335
190,072
173,202
143,087
157,683
148,691
157,610
161,330
150,732
147,573
155,515
69,514
25,924
179,602
164,402
337,381
358,234
358,234337,381164,402179,60225,92469,514155,515147,573150,732161,330157,610148,691157,683143,087173,202190,072144,335152,440162,443118,868117,236114,079118,810124,14643,600
   > Total Current Assets 
26,835
114,476
106,550
94,963
85,210
66,052
86,661
57,092
30,975
54,730
38,038
10,844
20,137
11,939
23,413
31,422
20,798
15,603
20,327
15,248
25,306
178,806
163,652
336,467
357,103
357,103336,467163,652178,80625,30615,24820,32715,60320,79831,42223,41311,93920,13710,84438,03854,73030,97557,09286,66166,05285,21094,963106,550114,47626,835
       Cash And Cash Equivalents 
11,531
102,981
95,608
83,728
73,022
54,304
78,632
51,043
26,025
48,665
34,206
6,974
14,059
5,543
15,940
16,160
5,311
5,735
10,228
4,632
21,644
173,992
159,085
334,474
354,349
354,349334,474159,085173,99221,6444,63210,2285,7355,31116,16015,9405,54314,0596,97434,20648,66526,02551,04378,63254,30473,02283,72895,608102,98111,531
       Net Receivables 
592
627
574
755
580
628
335
477
420
407
227
979
1,430
2,192
3,973
987
293
3,742
2,536
4,865
0
0
0
0
0
000004,8652,5363,7422939873,9732,1921,430979227407420477335628580755574627592
       Inventory 
3,211
2,312
2,797
2,415
3,867
3,978
2,992
1,802
1,980
1,312
1,291
1,749
2,188
2,850
2,545
4,498
4,829
4,866
6,214
4,823
0
0
0
0
0
000004,8236,2144,8664,8294,4982,5452,8502,1881,7491,2911,3121,9801,8022,9923,9783,8672,4152,7972,3123,211
       Other Current Assets 
11,501
8,556
7,570
8,065
7,741
7,143
4,702
3,771
2,550
4,346
2,315
1,143
2,461
1,354
955
9,777
10,366
1,260
1,349
928
3,662
4,814
4,567
1,993
2,754
2,7541,9934,5674,8143,6629281,3491,26010,3669,7779551,3542,4611,1432,3154,3462,5503,7714,7027,1437,7418,0657,5708,55611,501
   > Long-term Assets 
16,766
9,670
12,260
19,116
32,025
52,816
75,782
95,348
113,360
135,343
135,164
132,243
137,546
136,752
134,197
129,909
129,934
131,971
135,188
54,266
618
796
750
914
1,131
1,13191475079661854,266135,188131,971129,934129,909134,197136,752137,546132,243135,164135,343113,36095,34875,78252,81632,02519,11612,2609,67016,766
       Property Plant Equipment 
3,082
4,147
6,711
13,554
25,816
46,156
69,094
88,665
105,093
126,963
125,536
122,543
129,127
128,201
125,821
121,628
121,643
123,773
127,813
49,461
518
696
625
814
791
79181462569651849,461127,813123,773121,643121,628125,821128,201129,127122,543125,536126,963105,09388,66569,09446,15625,81613,5546,7114,1473,082
       Goodwill 
644
654
681
693
662
688
635
625
625
625
625
625
625
625
625
625
625
625
625
0
0
0
0
0
0
000000625625625625625625625625625625625625635688662693681654644
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
10010010010010000000000000000000000
       Intangible Assets 
12,329
4,159
4,159
4,159
4,159
4,228
4,305
4,333
5,493
5,313
6,383
6,352
6,301
6,240
6,184
6,127
6,074
6,024
5,979
4,036
0
0
0
0
0
000004,0365,9796,0246,0746,1276,1846,2406,3016,3526,3835,3135,4934,3334,3054,2284,1594,1594,1594,15912,329
       Long-term Assets Other 
710
710
710
710
1,388
1,744
1,749
1,725
2,149
2,441
2,619
2,723
1,493
1,685
1,566
1,529
1,591
1,548
771
769
0
0
25
0
240
240025007697711,5481,5911,5291,5661,6851,4932,7232,6192,4412,1491,7251,7491,7441,388710710710710
> Total Liabilities 
16,446
45,192
47,285
49,071
71,241
82,668
100,090
94,911
96,751
122,343
118,172
96,732
105,196
90,433
104,921
112,840
85,636
78,549
48,727
47,661
199,320
365,114
361,533
23,633
35,107
35,10723,633361,533365,114199,32047,66148,72778,54985,636112,840104,92190,433105,19696,732118,172122,34396,75194,911100,09082,66871,24149,07147,28545,19216,446
   > Total Current Liabilities 
10,778
10,350
13,208
17,813
23,701
32,338
33,922
22,900
25,607
34,563
35,383
29,682
18,597
19,149
29,346
45,305
17,548
10,411
18,825
11,296
58,168
15,143
12,981
19,080
27,775
27,77519,08012,98115,14358,16811,29618,82510,41117,54845,30529,34619,14918,59729,68235,38334,56325,60722,90033,92232,33823,70117,81313,20810,35010,778
       Short-term Debt 
969
1,019
3,125
6,520
9,895
13,104
12,154
2,978
6,143
12,025
15,067
10,298
10,104
10,242
23,750
23,299
3,474
4,266
11,789
4,920
45,051
6,296
6,298
6,273
6,202
6,2026,2736,2986,29645,0514,92011,7894,2663,47423,29923,75010,24210,10410,29815,06712,0256,1432,97812,15413,1049,8956,5203,1251,019969
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,857
6,000
6,000
6,000
6,000
6,0006,0006,0006,00044,85700000000000000000000
       Accounts payable 
513
76
238
29
546
2,637
859
983
17,153
17,172
16,429
15,834
4,734
5,118
5,478
6,022
4,622
5,943
6,845
6,153
1,866
2,317
1,465
2,098
1,996
1,9962,0981,4652,3171,8666,1536,8455,9434,6226,0225,4785,1184,73415,83416,42917,17217,1539838592,6375462923876513
       Other Current Liabilities 
8,119
8,555
9,106
10,592
12,655
16,504
19,901
16,664
223
204
148
112
95
119
118
14,612
9,324
203
-6,845
-6,153
7,938
6,530
5,218
10,709
11,751
11,75110,7095,2186,5307,938-6,153-6,8452039,32414,6121181199511214820422316,66419,90116,50412,65510,5929,1068,5558,119
   > Long-term Liabilities 
2,932
27,946
25,327
23,292
20,153
19,697
20,489
34,781
36,570
46,646
41,288
30,235
28,542
26,974
30,977
29,279
30,451
31,168
25,649
32,926
141,152
349,971
348,552
4,553
7,332
7,3324,553348,552349,971141,15232,92625,64931,16830,45129,27930,97726,97428,54230,23541,28846,64636,57034,78120,48919,69720,15323,29225,32727,9462,932
> Total Stockholder Equity
27,154
78,954
71,525
65,008
45,995
36,200
62,353
57,529
47,584
67,729
55,030
46,355
52,487
58,257
52,689
48,491
65,096
69,024
106,789
21,853
-173,396
-185,512
-197,131
313,748
323,127
323,127313,748-197,131-185,512-173,39621,853106,78969,02465,09648,49152,68958,25752,48746,35555,03067,72947,58457,52962,35336,20045,99565,00871,52578,95427,154
   Common Stock
104
184
184
186
186
186
218
218
218
259
259
262
288
288
288
306
348
371
521
521
0
0
1
0
0
00100521521371348306288288288262259259218218218186186186184184104
   Retained Earnings -252,811-231,682-208,275-194,694-181,702-318,919-234,850-227,801-220,662-220,768-210,583-204,425-209,236-198,290-190,492-183,750-169,724-161,466-157,109-148,948-134,955-115,044-106,086-97,252-91,326
   Accumulated Other Comprehensive Income 
-756
-674
-275
-374
-964
56
-2,751
-4,633
-7,830
-8,175
-13,118
-15,157
-10,872
-10,741
-11,118
-12,564
-12,170
-10,658
-10,632
-12,559
164
185
167
109
245
245109167185164-12,559-10,632-10,658-12,170-12,564-11,118-10,741-10,872-15,157-13,118-8,175-7,830-4,633-2,75156-964-374-275-674-756
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
119,133
176,696
177,701
180,240
181,728
184,906
221,995
223,410
224,920
259,395
258,382
259,540
272,307
273,136
274,102
281,517
297,579
307,111
351,750
352,810
8,142
8,997
10,977
545,321
575,693
575,693545,32110,9778,9978,142352,810351,750307,111297,579281,517274,102273,136272,307259,540258,382259,395224,920223,410221,995184,906181,728180,240177,701176,696119,133



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-78,194
Operating Income-78,194-78,194
 
Operating Expense (+$)
Research Development59,036
Selling General Administrative19,158
Selling And Marketing Expenses0
Operating Expense78,19478,194
 
Net Interest Income (+$)
Interest Income9,629
Interest Expense--2,367
Other Finance Cost-4,734
Net Interest Income7,262
 
Pretax Income (+$)
Operating Income-78,194
Net Interest Income7,262
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-71,109-85,279
EBIT - interestExpense = 2,367
-142,218
-73,476
Interest Expense-2,367
Earnings Before Interest and Taxes (EBIT)0-73,476
Earnings Before Interest and Taxes (EBITDA)-78,194
 
After tax Income (+$)
Income Before Tax-71,109
Tax Provision-0
Net Income From Continuing Ops-71,109-71,109
Net Income-71,109
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net7,085-7,262
 

Technical Analysis of BioAge Labs, Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioAge Labs, Inc. The general trend of BioAge Labs, Inc is BEARISH with 64.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioAge Labs, Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-64.3%) Bearish trend (64.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. BioAge Labs, Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioAge Labs, Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.85 < 4.05 < 4.12.

The bearish price targets are: .

Know someone who trades $BIOA? Share this with them.πŸ‘‡

BioAge Labs, Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioAge Labs, Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -9/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioAge Labs, Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioAge Labs, Inc. The current macd is -0.23519378.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioAge Labs, Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for BioAge Labs, Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the BioAge Labs, Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioAge Labs, Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioAge Labs, Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioAge Labs, Inc. The current adx is 42.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell BioAge Labs, Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
BioAge Labs, Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioAge Labs, Inc. The current sar is 2.969488.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BioAge Labs, Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioAge Labs, Inc. The current rsi is 47.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
BioAge Labs, Inc Daily Relative Strength Index (RSI) ChartBioAge Labs, Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioAge Labs, Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioAge Labs, Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioAge Labs, Inc Daily Stochastic Oscillator ChartBioAge Labs, Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioAge Labs, Inc. The current cci is -5.47057036.

BioAge Labs, Inc Daily Commodity Channel Index (CCI) ChartBioAge Labs, Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioAge Labs, Inc. The current cmo is 7.6795672.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioAge Labs, Inc Daily Chande Momentum Oscillator (CMO) ChartBioAge Labs, Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioAge Labs, Inc. The current willr is -25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that BioAge Labs, Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioAge Labs, Inc Daily Williams %R ChartBioAge Labs, Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of BioAge Labs, Inc.

BioAge Labs, Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioAge Labs, Inc. The current atr is 0.26776508.

BioAge Labs, Inc Daily Average True Range (ATR) ChartBioAge Labs, Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioAge Labs, Inc. The current obv is 2,775,986.

BioAge Labs, Inc Daily On-Balance Volume (OBV) ChartBioAge Labs, Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioAge Labs, Inc. The current mfi is 19.75.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
BioAge Labs, Inc Daily Money Flow Index (MFI) ChartBioAge Labs, Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioAge Labs, Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-31MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

BioAge Labs, Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioAge Labs, Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.034
Ma 20Greater thanMa 503.768
Ma 50Greater thanMa 1004.155
Ma 100Greater thanMa 2006.400
OpenGreater thanClose3.770
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BioAge Labs, Inc with someone you think should read this too:
  • Are you bullish or bearish on BioAge Labs, Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioAge Labs, Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioAge Labs, Inc

I send you an email if I find something interesting about BioAge Labs, Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioAge Labs, Inc.

Receive notifications about BioAge Labs, Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.